BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36741724)

  • 21. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
    Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis.
    Wu J; Ma S; Sun L; Qin Z; Wang Z; Wang N; Lin M
    Acta Haematol; 2021; 144(6):603-612. PubMed ID: 34044389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
    Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
    Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.
    Cheng CL; Huang SC; Chen JH; Wei CH; Fang WQ; Su TH; Yuan CT; Liu JH; Chuang MK; Tien HF
    Oncologist; 2020 Sep; 25(9):793-802. PubMed ID: 32275807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
    Huang Z; Wang K; Huang S; Lu Q
    Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
    Allison E; Edirimanne S; Matthews J; Fuller SJ
    Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
    Chen X; Liang R; Lai L; Chen K; Zhu X
    Front Oncol; 2021; 11():697369. PubMed ID: 34490092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.
    Nam SJ; Go H; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2014 Nov; 55(11):2466-76. PubMed ID: 24397616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.
    Mei J; Xiao Z; Guo C; Pu Q; Ma L; Liu C; Lin F; Liao H; You Z; Liu L
    Oncotarget; 2016 Jun; 7(23):34217-28. PubMed ID: 27144518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
    Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
    Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status.
    Croci GA; Au-Yeung RKH; Reinke S; Staiger AM; Koch K; Oschlies I; Richter J; Poeschel V; Held G; Loeffler M; Trümper L; Rosenwald A; Ott G; Spang R; Altmann B; Ziepert M; Klapper W
    Ann Oncol; 2021 Nov; 32(11):1400-1409. PubMed ID: 34438040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review.
    Xu PP; Shen R; Shi ZY; Cheng S; Wang L; Liu Y; Zhang L; Huang R; Ma X; Wu X; Yao H; Yu Y; Zhao WL
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1051-e1058.e1. PubMed ID: 36182550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis.
    Wang YM; Cai W; Xue QM; Zhang JY; Zhou L; Xiong SY; Deng H
    Front Immunol; 2023; 14():1234894. PubMed ID: 37654479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis.
    Luan C; Wang F; Wei N; Chen B
    Cancer Cell Int; 2020; 20():455. PubMed ID: 32973400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis.
    He X; Chen Z; Fu T; Jin X; Yu T; Liang Y; Zhao X; Huang L
    BMC Cancer; 2014 Mar; 14():153. PubMed ID: 24597851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis.
    Yao L; Xu H; Wo J; Zhao M; Liu Z; Dong T; Xiao S
    Clin Exp Med; 2022 Feb; 22(1):1-7. PubMed ID: 33990849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.
    Chu MP; Lieffers J; Ghosh S; Belch A; Chua NS; Fontaine A; Sangha R; Turner RA; Baracos VE; Sawyer MB
    J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):298-304. PubMed ID: 27897411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas].
    Huo YJ; Zhang MC; Shi Q; Qin W; Shi ZY; Wang L; Cheng S; Xu PP; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):55-61. PubMed ID: 36987724
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
    Xian F; Ren D; Bie J; Xu G
    Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.